Page 7 - Nifty Pharma

Ravi Nathani recommends to wait for correction to complete in these sectors

According to the technical analyst, the Nifty Realty, Pharma and Media index and its constituents can be accumulated once the corrective move is over.

Pharma, Energy, Commodities indices look bearish on charts: Ravi Nathani

According to the technical analyst, the Nifty Energy index can drop to 24,239, and the Pharma to 12,100.

Trend looks bullish on Nifty Pharma, Media indices, says Ravi Nathani

According to the technical analyst, the Nifty Pharma index can rally up to 13,250 level, while the Media index can surge to 2,080 level.

Tech view: Check key levels on Sensex, Nifty as trend remains indecisive

The overall sentiment towards the market has remained indecisive and ambiguous, with market participants waiting for a clear direction

Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

Pharma shares may turnaound soon; Cipla, Sun Pharma, Granules can gain 20%

What do expect from pharma stocks over the next few weeks? Here's what technical charts suggest.

Cash is king! Investing strategies to ride out choppy markets

They turn cautious and prefer defensive bets

Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

The Pharma benchmark has outperformed the overall market in recent trading sessions; sustenance above 200-DMA is likely to trigger further gains for it

Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs

Shares of Glenmark Pharma, Granules India, Divi's Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday's intra-day trade

Prescription for recovery in FY23 for underperforming pharma sector

Easing pricing pressures, complex generics uptick in the US, steady India/emerging-market growth potential booster shots

Growth forecast in US market set to drive gains for Cipla stock

Street remains bullish on India prospects, regulatory headwinds for Goa site continue

Nifty Pharma index sees biggest jump in four months, shows data

The Nifty Pharma index finished at 12,750, up 3.1 per cent - most since May 20 and third biggest single-day gain of the year

Strong specialty sales and volumes keep it sunny for Sun Pharma

Rerating on the cards; the domestic business is expected to outperform

Glenmark, Alembic, Cipla: Pharma stocks on a booster dose this December

Select pharma stocks look good on the technical charts and may jump up to 15 per cent in December. On the fundamental side, fears of Omicron variant spreading may also keep them in news and buzzing

Most sectoral indices fall back despite broader market rally in past 2 yrs

Large part of gains in two years accrued to top companies in metals, IT, pharma and realty

Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results

Nifty Pharma index hits new high; Aurobindo, Dr Reddy's gain over 3%

Marksans Pharma and Novartis India from the S&P BSE Healthcare index zoomed 20 per cent each

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50; Sun Pharma scales 4-year high

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index

Pharma index hits record high as govt launches phase 3 of Covid vaccination

Cipla, Gland Pharma, JB Chemicals and Pharma, Max Healthcare, Neuland Lab and Apollo Hospital from BSE Healthcare index hit their respective record highs today